viewArcadia Biosciences Inc

Arcadia Biosciences closes registered direct offering that raised about $10 million

The agribiotech intends to use the money to acquire hemp germplasm, for breeding and research, and to scale-up its flagship GoodWheat's portfolio

Arcadia Biosciences Inc - Arcadia Biosciences closes on registered direct offering that raised about $10 million
Arcadia develops high-value food ingredients and nutritional oils that aim to meet the demand for healthier diets

Arcadia Biosciences Inc (NASDAQ:RKDA), the food-ingredient company, announced Tuesday that it has closed on a registered direct offering that raised about $10 million.

In a statement, the company said it sold 1.3 million shares at an on-the-market price of $7.52 each.

Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 659,414 shares of common stock, representing 50% of the shares of common stock purchased in the direct offering. 

READ: Arcadia Biosciences forms hemp extraction joint venture with Legacy Ventures Hawaii

Each warrant was sold at a price of $0.125 per underlying share for gross proceeds of about $82,000. Each warrant has an exercise price of $7.52 per share, exercisable immediately, and will expire five and one-half years from the issuance date.

Arcadia said it intends to use the net proceeds for general corporate purposes and to pursue a range of near-term growth opportunities -- such as the acquisition of hemp germplasm, breeding and research, and a scale-up of its flagship GoodWheat portfolio of wheat flour products. 

"The proceeds of this financing, coupled with just over $5 million in cash we received from warrant exercises over the past week by investors from prior financings, meaningfully improves our cash position and better enables us to pursue a broad range of growth opportunities in the near term," said Arcadia CEO Matthew Plavan.

Arcadia, based in Davis, California, is an agricultural biotech company that develops high-value food ingredients and nutritional oils that aim to meet the demand for healthier diets. It also produces a GMO soybean.

The company’s stock recently traded up 1.7% to $6.51 per share. 

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Arcadia Biosciences Inc


Price: 2.06 USD

Market Cap: $45.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Arcadia Biosciences describes expected synergies with its recent CBD-focused...

Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17DN) CEO Matt Plavan describes to Proactive why the group recently acquired CBD-focused Lief Holdings, LLC and Live Zola, LLC. Plavan says in addition to bringing in a 'significant amount of recurring revenue' he sees synergies within the two groups,...

on 05/19/2021

2 min read